Education

• MD, University of Pittsburg School of Medicine, Pittsburg, PA, 2000
• Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY, 2007-2009
• Residency in General Surgery, University of North Carolina, Chapel Hill, NC, 2000-2005
• National Research Service Award Fellow, Agency for Healthcare Research and Quality, Weill Medical College of Cornell University, New York, NY, 2005-2007
• Research Fellow in Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007
• MS, Weill Graduate School in Medical Sciences of Cornell University, New York, NY, 2007

Clinical Specialties

Dr. Neuman specializes in surgical oncology with a focus on breast, melanoma and sarcoma. She is certified by the American Board of Surgery.

Dr. Neuman provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Lymph Node Dissection, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Radical Resection Soft Tissue Tumor, Sarcoma Removal of Retroperitoneal/intraabdominal Soft Tissue Tumors (Sarcomas), Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy, and Wide Local Excision Skin With Reconstruction.

Research Interests

Dr. Neuman’s research focuses on patient-oriented clinical outcomes including patient decision-making, quality of life and survivorship.

Active Clinical Trials

• A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node
  Principal Investigator(s): Heather B Neuman, MD, MS
  Status: Recruiting
  [ClinicalTrials.gov: NCT00297895]
  More Information

Recent Publications

• Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment.
  Neuman HB, Patil S, Fuzesi S, Wong WD, Weiser MR, Guillem JG, Paty PB, Nash GM, Temple LK
  Ann. Surg. Oncol. 2011 May; 18(5):1397-403.
  [PubMed ID: 21128000]
  More Information
• Risk-reducing surgery in FAP: role for surgeons beyond the incision.
  Neuman HB, Robbins L, Duarte J, Charlson ME, Weiser MR, Guillem JG, Wong WD, Temple LK
  J Surg Oncol 2010 Jun 1; 101(7):570-6.
  [PubMed ID: 20461762]
  More Information
• Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?
  Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA
  Cancer 2010 Mar 1; 116(5):1226-33.
  [PubMed ID: 20101736]
  More Information
• Randomized clinical trials in rectal and anal cancers.
  Park J, Neuman HB, Weiser MR, Wong WD
  Surg. Oncol. Clin. N. Am. 2010 Jan; 19(1):205-23.
  [PubMed ID: 19914567]
  More Information
• Randomized clinical trials in colon cancer.
  Neuman HB, Park J, Weiser MR
  Surg. Oncol. Clin. N. Am. 2010 Jan; 19(1):183-204.
  [PubMed ID: 19914566]
  More Information